Amgen (AMGN) Financials
Amgen (AMGN) Historical Financial Statements and Key Metrics for 1986 - 2026
Full Amgen financials for 1986 - 2026 are available in the
US Historical Financials dataset
All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.
Amgen Income Statements
(in $ 000,000's)
| Quarter End | Revenue | Gross Profit | Operating Income | Net Income | EBITDA | EPS |
| 2026-Jun-30 | 10,054 | 7,243 (72.0 %) | 3,514 (35.0 %) | 2,375 (23.6 %) | 3,441 | 4.37 |
| 2026-Mar-31 | 8,618 | 5,874 (68.2 %) | 2,666 (30.9 %) | 1,819 (21.1 %) | 3,857 | 3.34 |
| 2025-Dec-31 | 9,896 | 8,106 (81.9 %) | 3,942 (39.8 %) | 1,333 (13.5 %) | 5,074 | 2.45 |
| 2025-Sep-30 | 9,557 | 6,475 (67.8 %) | 2,526 (26.4 %) | 3,216 (33.7 %) | 5,913 | 5.93 |
| 2025-Jun-30 | 9,167 | 6,156 (67.2 %) | 2,644 (28.8 %) | 1,432 (15.6 %) | 3,617 | 2.65 |
| 2025-Mar-31 | 8,149 | 5,181 (63.6 %) | 1,178 (14.5 %) | 1,730 (21.2 %) | 1,178 | 3.20 |
| 2024-Dec-31 | 9,086 | 5,974 (65.7 %) | 2,311 (25.4 %) | 627 (6.9 %) | 2,926 | 1.16 |
Full historical income statements for 1986 - 2026 is included in the
US Historical Financials dataset.
Amgen Balance Sheets
(in $ 000,000's)
| Quarter End | Total Assets | Total Liabilities | Total Debt | Total Equity | Cash & Equivalents |
| 2026-Jun-30 | 95,639 | 83,951 | 57,304 | 11,688 | 13,989 |
| 2026-Mar-31 | 92,504 | 83,314 | 57,323 | 9,190 | 12,038 |
| 2025-Dec-31 | 90,586 | 81,928 | 54,604 | 8,658 | 9,129 |
| 2025-Sep-30 | 90,141 | 80,522 | 54,587 | 9,619 | 9,445 |
| 2025-Jun-30 | 87,897 | 80,469 | 56,204 | 7,428 | 8,028 |
| 2025-Mar-31 | 89,367 | 83,160 | 57,381 | 6,207 | 8,810 |
| 2024-Dec-31 | 91,839 | 85,962 | 60,099 | 5,877 | 11,973 |
Full historical balance sheet data for 1986 - 2026 is included in the
US Historical Financials dataset.
Amgen Cash Flow Statements
(in $ 000,000's)
| Quarter End | Operating Cash Flow | Investing | Financing | Free Cash Flow |
| 2026-Jun-30 | 4,002 | -569 | -1,482 | 3,489 |
| 2026-Mar-31 | 2,189 | -716 | 1,436 | 1,477 |
| 2025-Dec-31 | 1,603 | -693 | -1,226 | 961 |
| 2025-Sep-30 | 4,684 | -414 | -2,853 | 4,248 |
| 2025-Jun-30 | 2,280 | -389 | -2,673 | 1,911 |
| 2025-Mar-31 | 1,391 | -447 | -4,107 | 980 |
| 2024-Dec-31 | 4,771 | -402 | -1,407 | 4,400 |
Full historical cash flow data for 1986 - 2026 is included in the
US Historical Financials dataset.
Amgen Key Valuation and Operating Metrics
| Quarter End | Market Capitalization ($ 000,000's) |
Enterprise Value ($ 000,000's) |
Price/Earnings ($ 000,000's) |
Price/Sales ($ 000,000's) |
Price/Book ($ 000,000's) |
| 2026-Jun-30 | 195,545 | 238,860 | 19.45 | 20.58 | 16.73 |
| 2026-Mar-31 | 189,999 | 235,284 | 22.05 | 26.10 | 20.67 |
| 2025-Dec-31 | 176,420 | 221,895 | 17.83 | 33.09 | 20.38 |
| 2025-Sep-30 | 151,824 | 196,966 | 15.89 | 11.80 | 15.78 |
| 2025-Jun-30 | 150,215 | 198,391 | 16.39 | 26.22 | 20.22 |
| 2025-Mar-31 | 167,614 | 216,185 | 20.57 | 24.22 | 27.00 |
| 2024-Dec-31 | 140,880 | 189,006 | 15.51 | 56.17 | 23.97 |
Full historical valuation and operating metrics for 1986 - 2026 are included in the
US Historical Financials dataset.